Skip to main content
IONS
NASDAQ Life Sciences

Ionis Cuts TRYNGOLZA 2026 Guidance to ~$50M as Q3 Loss Widens

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$31.17
Mkt Cap
$5.152B
52W Low
$27.75
52W High
$86.74
52W Position info
12% above low
Off High info
64% below high
Rel. Volume info
5.6× avg
Market data snapshot near publication time

IONS is trading near its 52-week low of $27.75 (12% above the low) on elevated volume (5.6× avg).

Summary

Ionis posted Q3 2026 revenue of $243 million, up 54.8% year over year, but the net loss widened to $110 million, or $0.66 a share. The bigger problem is TRYNGOLZA: management cut 2026 sales guidance to about $50 million, a steep markdown from the roughly $100 million figure circulated with yesterday's release, while revenue and cash outlooks were left unchanged. The pipeline readout was mixed — sefaxersen and ulefnersen hit their Phase 3 goals, but pelacarsen and eplontersen missed. HIBSAGO is the offset, winning approvals in the U.S., Japan and Canada and triggering a $30 million milestone, with royalties to follow as the global launch begins. The analyst consensus stays Buy, though the average 12-month price target slipped to $83.38 from $84.90 as several firms trimmed. Next specific checkpoint: the EU's final decision on TRYNGOLZA for severe hypertriglyceridemia, expected in Q4 2026.

At the time of this announcement, IONS was trading at $31.17 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.2B. The 52-week trading range was $27.75 to $86.74. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

IONS - Latest Insights

IONS
Nov 09, 2026, 11:01 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $28.67
Real-time Price: $31.14 info
Change: +$2.48 (+9%) info
Market Cap: $5.152B info
IONS
Nov 09, 2026, 8:33 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $31.50
Real-time Price: $31.14 info
Change: -$0.360 (-1%) info
Market Cap: $5.152B info
IONS
Nov 09, 2026, 7:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.00
Real-time Price: $31.14 info
Change: -$5.86 (-16%) info
Market Cap: $5.152B info
IONS
Nov 09, 2026, 7:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $37.00
Real-time Price: $31.14 info
Change: -$5.86 (-16%) info
Market Cap: $5.152B info
IONS
Oct 23, 2026, 1:41 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $42.93
Real-time Price: $31.14 info
Change: -$11.79 (-27%) info
Market Cap: $5.152B info